135 related articles for article (PubMed ID: 7775835)
1. Tumour oxygenation, radiosensitivity, and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration.
Thomas CD; Prade M; Guichard M
Int J Radiat Biol; 1995 May; 67(5):597-605. PubMed ID: 7775835
[TBL] [Abstract][Full Text] [Related]
2. Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration.
Thomas CD; Stern S; Chaplin DJ; Guichard M
Radiother Oncol; 1996 Jun; 39(3):235-41. PubMed ID: 8783400
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide and carbogen: relationship between pO2 and radiosensitivity in three tumour lines.
Martin LM; Thomas CD; Guichard M
Int J Radiat Biol; 1994 Mar; 65(3):379-86. PubMed ID: 7908317
[TBL] [Abstract][Full Text] [Related]
4. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
Thomas CD; Chavaudra N; Martin L; Guichard M
Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
[TBL] [Abstract][Full Text] [Related]
5. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
6. Tumor oxygenation after 1) carbogen and/or perflubron emulsion administration in tumor xenografts 2) carbogen administration in patients.
Guichard M; Lartigau E; Martin L; Thomas C; Weeger P; Lambin P; Le Ridant AM; Lusinchi A; Wibault P; Luboinski B
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1355-60. PubMed ID: 7849944
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injection.
Vitu-Loas L; Thomas C; Chavaudra N; Guichard M
Radiother Oncol; 1993 May; 27(2):149-55. PubMed ID: 8356225
[TBL] [Abstract][Full Text] [Related]
8. Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion carbogen breathing.
Teicher B; Sotomayor E; Robinson M; Dupuis N; Schwartz G; Frei E
Int J Oncol; 1993 Jan; 2(1):13-21. PubMed ID: 21573510
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two techniques for detecting tumour hypoxia: a fluorescent immunochemical method and an in vitro colony assay.
Stern S; Hodgkiss RJ; Guichard M
Radiother Oncol; 1996 May; 39(2):129-35. PubMed ID: 8735480
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
Stern S; Guichard M
Radiother Oncol; 1996 Nov; 41(2):143-9. PubMed ID: 9004358
[TBL] [Abstract][Full Text] [Related]
11. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
[TBL] [Abstract][Full Text] [Related]
12. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Honess DJ; Hill SA; Collingridge DR; Edwards B; Brauers G; Powell NA; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):731-5. PubMed ID: 9845086
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.
Simon JM; Lartigau E; Guichard M
Radiother Oncol; 1993 Sep; 28(3):203-7. PubMed ID: 8255997
[TBL] [Abstract][Full Text] [Related]
15. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
[TBL] [Abstract][Full Text] [Related]
16. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
Thomas C; Riess J; Guichard M
Int J Radiat Biol; 1991 Feb; 59(2):433-45. PubMed ID: 1671693
[TBL] [Abstract][Full Text] [Related]
17. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
Teicher BA; Sotomayor EA; Dupuis NP; Kusumoto T; Menon K
J Cancer Res Clin Oncol; 1994; 120(10):593-8. PubMed ID: 7929530
[TBL] [Abstract][Full Text] [Related]
18. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.
Bussink J; Kaanders JH; Rijken PF; Peters JP; Hodgkiss RJ; Marres HA; van der Kogel AJ
Radiother Oncol; 1999 Feb; 50(2):173-84. PubMed ID: 10368041
[TBL] [Abstract][Full Text] [Related]
19. Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
Laurence VM; Ward R; Dennis IF; Bleehen NM
Br J Cancer; 1995 Jul; 72(1):198-205. PubMed ID: 7599052
[TBL] [Abstract][Full Text] [Related]
20. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
